CRBP

Corbus Pharmaceuticals Holdings, Inc. Common Stock

$7.20 +$0.15 +2.08%



Shares Bought5
Shares Sold5
Total10
Shares Owned0
Last Price$7.20
Total Return$0.86
Range Today$6.65 - $7.35
52 Week Range$5.30 - $10.50
Open$7.05
Market Cap$354.07M
Volume/Average316.20K/782.78K
P/E Ratio-
Dividend/Yield-




Corbus Pharmaceuticals Holdings, Inc. engages in the development and commercialization of novel therapeutics to treat rare or uncommon chronic and serious inflammatory and fibrotic diseases with clear unmet medical needs. Its produc, JBT-101 is a novel synthetic oral endocannabinoid-mimetic drug that is intended to resolve chronic inflammation and halt fibrotic processes without causing immunosuppression. The company was founded in December 2013 and is headquartered in Norwood, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-30-17 16:54 12-04-17 16:04 $7.85 $7.60 -$0.25 -3.16% nasty_paladin
10-12-17 18:53 10-17-17 15:31 $6.80 $7.20 +$0.40 +5.90% lintaglen
10-12-17 18:54 10-17-17 15:32 $6.80 $7.20 +$0.40 +5.90% lintaglen
10-12-17 18:31 10-17-17 15:30 $6.85 $7.20 +$0.35 +5.12% lintaglen
09-14-17 20:58 09-15-17 15:05 $6.85 $6.80 -$0.05 -0.72% almightycat2